Picture of Faron Pharmaceuticals Oy logo

FARN — Faron Pharmaceuticals Oy News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Faron Pharmaceuticals H1 Operating Loss Narrows To EUR 11.3 Mln

Aug 27 (Reuters) - Faron Pharmaceuticals Oy  FARN.L :
    * HALF-YEAR FINANCIAL RESULTS
    * CASH BALANCES OF EUR 30.0 MILLION ON JUNE 30, 2024 (2023:
EUR
6.3 MILLION)
    * OPERATING LOSS OF EUR 11.3 MILLION FOR SIX MONTHS ENDED
JUNE 30,
2024 (2023: EUR 12.8 MILLION)

Source text for Eikon:  ID:nWkr1jdxTz 
Further company coverage:  FARN.L 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Faron Pharmaceuticals Oy

See all news